Lakefront Biotherapeutics
LKFT

Lakefront Biotherapeutics (LKFT) stock price, chart and financials

Price chart

−13.16% over 1Y
Oct 14, 2025Low $26.08 · High $34.64Oct 14, 2026

Company profile

Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.

Frequently asked questions

  • How do I buy stock in Lakefront Biotherapeutics (LKFT)?

    LKFT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.